stock.name

NovoCure Ltd

NVCR

Market Cap$1.49B
Close$

Compare NovoCure Ltd

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
NovoCure LtdNovoCure Ltd-7.20%-57%3.71.6
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$15.22

Current Fair Value

4% upside

Undervalued by 4% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.49 Billion
Enterprise Value$1.15 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.95
Beta1.56
Outstanding Shares107,093,432
Avg 30 Day Volume1,051,610

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-7.22
PEG-27.53
Price to Sales3.66
Price to Book Ratio4.88
Enterprise Value to Revenue2.26
Enterprise Value to EBIT-4.95
Enterprise Value to Net Income-6
Total Debt to Enterprise0.49
Debt to Equity1.57

Revenue Sources

No data

ESG Score

No data

About NovoCure Ltd

CEO: Asaf Danziger